Quadrant Private Wealth Management, LLC Century Therapeutics, Inc. Transaction History
Quadrant Private Wealth Management, LLC
- $468 Million
- Q2 2025
A detailed history of Quadrant Private Wealth Management, LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Quadrant Private Wealth Management, LLC holds 15,286 shares of IPSC stock, worth $8,254. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,286Holding current value
$8,254% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IPSC
# of Institutions
74Shares Held
27.5MCall Options Held
12.1KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$2.92 Million0.87% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$1.73 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.56 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.5MShares$1.35 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.28 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $31.8M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...